Permanently Discontinued

BUPIVACAINE HYDROCHLORIDE IN DEXTROSE INJECTION USP

STERIMAX INC

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is BUPIVACAINE HYDROCHLORIDE IN DEXTROSE INJECTION USP discontinued in Canada?

Yes. The manufacturer has reported to Health Canada that BUPIVACAINE HYDROCHLORIDE IN DEXTROSE INJECTION USP 7.5MG has been permanently discontinued (last updated October 27, 2026). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.

Why is BUPIVACAINE HYDROCHLORIDE IN DEXTROSE INJECTION USP not available?

The reason the manufacturer reported: Business reasons.

Can I still get this?Check with your pharmacist — only products with a different form or route found

StatusPermanently Discontinued

Same-ingredient products on file3 products · 0 same form & route

Affected strength7.5MG

Report last updated2026-10-27

Checked by MedShort2026-11-12

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Other Products

BUPIVACAINE HYDROCHLORIDE INJECTION, USP

BAXTER CORPORATION

7.5MG · DIN 02488930

Same strengthSame dosage formDifferent routeNo current shortage

Compare these two →

SENSORCAINE

ASPEN PHARMACARE CANADA INC.

2.5MG · DIN 01976141

Different strengthSame dosage formDifferent routeNo current shortage

Compare these two →

BUPIVACAINE INJECTION BP

STERIMAX INC

5MG · DIN 02443694

Different strengthSame dosage formDifferent routeNo current shortage

Compare these two →

What this means

Does this mean I need to switch medications right away?

Not necessarily right away, but this product will not be returning to the market.

What should I do?

Talk to your pharmacist or prescriber about your options well before your current supply runs out.

DIN

02460645

Strength

7.5MG

Dosage Form

SOLUTION

Route

INTRASPINAL

Active Ingredient

BUPIVACAINE HYDROCHLORIDE

Tier

Unrated

Last Updated

2026-10-27

Reason for Shortage

Business reasons

Source

View original report on healthproductshortages.ca ↗

Past Reports for This Drug

BUPIVACAINE HYDROCHLORIDE IN DEXTROSE INJECTION USP has 2 shortage/discontinuation reports on file — this is one of them.

2024-08-12

Shortage Avoided

Disruption of the manufacture of the drug.

Other Products from STERIMAX INC

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

ACETAZOLAMIDE FOR INJECTION, USP

500MG · DIN 02358328

ACETYLCYSTEINE SOLUTION USP

200MG · DIN 02538431

ACYCLOVIR SODIUM INJECTION

50MG · DIN 02456524

APRESOLINE

20MG · DIN 00723754

ARSENIC TRIOXIDE FOR INJECTION

1MG · DIN 02492768

AZITHROMYCIN FOR INJECTION USP

500MG · DIN 02483890